Odefsey Prices, Coupons, Copay Cards & Patient Assistance
Odefsey (emtricitabine/rilpivirine/tenofovir alafenamide) is a member of the antiviral combinations drug class and is commonly used for HIV Infection.
Odefsey is available as a brand name drug only, a generic version is not yet available. View generic Odefsey availability for more details.
Odefsey prices
Oral Tablet
200 mg-25 mg-25 mg Odefsey oral tablet from $3,755.85 for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $125.20 | $3,755.85 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Odefsey Coupons, Copay Cards and Rebates
Odefsey offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Odefsey Advancing Access Co-pay Program
Eligible commercially insured patients may save up to a maximum of $6000 per year with no monthly limits
- Applies to:
- Odefsey
- Number of uses:
- per prescription per year
Form more information phone: 800-226-2056 or Visit website
Odefsey Advancing Access Co-pay Program Direct Member Reimbursement
Eligible commercially insured patients may be eligible for reimbursement if they were enrolled in the Co-pay Program but paid in full out of pocket for their medication.
- Applies to:
- Odefsey
- Number of uses:
- One rebate per prescription fill
Form more information phone: 800-226-2056 or Visit website
Patient Assistance & Copay Programs for Odefsey
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Advancing Access Program
Eligibility requirements:- Must be uninsured or underinsured
- At or below 500% of FPL
- Medically appropriate condition/diagnosis
- Must be residing in the US or Puerto Rico
- This program is for outpatient use only. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. This Program participates in the CPAPA. This single common application allows uninsured HIV-positive individuals with low incomes to use one application to apply for multiple assistance programs. *IMPORTANT: Send completed CPAPA to the corresponding addresses listed for each company.
- Odefsey (emtricitabine-rilpivirine-tenofovir alafenamide) Tablet
More information please phone: 800-226-2056 Visit website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Odefsey (emtricitabine-rilpivirine-tenofovir alafenamide) Tablet
More information please phone: 866-316-7263 Visit website
Provider: Good Days Program
Eligibility requirements:- Must have insurance
- At or below 500% of FPL
- FDA-approved diagnosis
- The patient must also be a US resident with a Social Security Number.
- Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
- Odefsey (emtricitabine-rilpivirine-tenofovir alafenamide) Tablet
More information please phone: 877-968-7233 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Cabenuva
Cabenuva (cabotegravir and rilpivirine) injections are a long-acting HIV treatment used to keep HIV ...
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Atripla
Atripla prevents the human immunodeficiency virus (HIV) from reproducing in your body. Learn about ...
Complera
Complera (emtricitabine, rilpivirine, and tenofovir) is used to treat HIV infection. Includes ...
Stribild
Stribild (cobicistat, elvitegravir, emtricitabine and tenofovir) is used to treat HIV-1 infection ...
Epzicom
Epzicom is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Learn ...
Emtricitabine
Emtricitabine is used for HIV Infection, nonoccupational exposure, occupational exposure
More about Odefsey (emtricitabine / rilpivirine / tenofovir alafenamide)
- Check interactions
- Compare alternatives
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations